Results 41 to 50 of about 2,449,966 (235)

Familial Micronodular Adrenocortical Disease, Cushing Syndrome, and Mutations of the Gene Encoding Phosphodiesterase 11A4 ( PDE11A) [PDF]

open access: yes, 2014
We present the pathologic findings in the adrenal glands of 4 patients, aged 10 to 38 years, with Cushing syndrome and germline inactivating mutations of the gene PDE11A4 that encodes phosphodiesterase11A4. The gene is expressed in the adrenal cortex and
Bertherat, J.   +3 more
core   +1 more source

Internal jugular vein adrenocorticotropic hormone estimation for diagnosis of adrenocorticotropic hormone-dependent Cushing′s syndrome: Ultrasound-guided direct jugular vein sample collection

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Aim of Study: To assess the utility of internal jugular vein (IJV) / peripheral adrenocorticotropic hormone (ACTH) gradient in determining the etiology of ACTH- dependent Cushing′s syndrome.
Jaya Prakash Sahoo   +4 more
doaj   +1 more source

Additional file 1: of Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushingâ s syndrome

open access: yes, 2018
Summary table type of PRO and study design per reference. A table summarizing the type of PRO and study design per reference. (DOCX 27 kb)
Knoble, Naomi   +3 more
openaire   +1 more source

Cushing's syndrome: Treatment and new therapeutic approaches.

open access: yesBest practice & research. Clinical endocrinology & metabolism, 2020
Overt Cushing's syndrome is a severe condition responsible for multiple comorbidities and increased mortality. Effective treatment is essential to reduce mortality, improve comorbidities and long-term quality of life.
A. Ferriere, A. Tabarin
semanticscholar   +1 more source

Management of germ cell tumors in children: Approaches to cure [PDF]

open access: yes, 2002
The introduction of cisplatinum chemotherapy and current advances in the surgical treatment have resulted in a dramatic improvement of the prognosis of children with malignant germ cell tumors (GCT).
Calaminus, G.   +4 more
core   +1 more source

Additional file 2: of Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushingâ s syndrome

open access: yes, 2018
Sub-domains of PRO assessed per PRO. A table summarizing the sub-domains of PRO assessed per PRO. (DOCX 18 kb)
Knoble, Naomi   +3 more
openaire   +1 more source

Anaesthetic management of a patient with Cushing′s syndrome and non-compaction cardiomyopathy for adrenal tumour resection

open access: yesIndian Journal of Anaesthesia, 2012
We describe the anaesthetic management of adrenalectomy in a patient with Cushing′s syndrome due to adrenal mass with coexisting non-compaction cardiomyopathy.
Akilandeswari Manickam   +2 more
doaj   +1 more source

Impact of Adrenalectomy on Morbidity in Patients with Non-Functioning Adrenal Cortical Tumours, Mild Hypercortisolism and Cushing’s Syndrome as Assessed by National and Quality Registries

open access: yesWorld Journal of Surgery, 2021
The impact of adrenalectomy on morbidity in patients with mild hypercortisolism and non-functioning adrenocortical adenoma is unclear. The present study evaluated morbidity before and after adrenalectomy in patients with benign adrenocortical tumour with
L. Thompson   +4 more
semanticscholar   +1 more source

Harvey Cushing and Philip Hench: pituitary basophilism meets cortisone excess [PDF]

open access: yes, 2007
Universidade Federal de São Paulo (UNIFESP) Departamento de Medicina Disciplina de EndocrinologiaUniversidade Federal de Pernambuco Hospital das Clínicas Divisão de EndocrinologiaUniversity of Sheffield School of Medicine and Biomedical Science ...
Kater, Claudio Elias   +2 more
core   +1 more source

Role of Prednisone and 25‐Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective We evaluated the role of 25‐hydroxyvitamin D (25[OH]D), prednisone, and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25(OH)D levels and other potential risk factors and BMD measures (spine T scores) and osteoporosis (defined as a T ...
Nima Madanchi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy